On the development of slowly-turning-over cell types in neonatal rat bone marrow (studies utilizing the complete tritiated thymidine labelling method complemented by C-14 thymidine administration).

1. The continuous H3-thymidine (H3-TdR) intravenous infusion of rats from day 9 of pregnancy until term results in the labeling of every single cell nucleus in the body of the offspring. Completely labeled newborn rats were sacrificed at serial intervals after birth. This provided the opportunity to follow the labeling pattern of all bone marrow cells during the development of this organ. Cytokinetically three types of cell renewal systems could be found: one type showed a rapid turnover losing all H3-TdR within 6 days, e.g., erythropoietic and myelopoietic cells. Another lost most of its labeling throughout the same time except a small but significant fraction (bone marrow lymphocytes). The third retained a high fraction of labeled cells with a high labeling intensity for weeks and months (reticular cells and endothelial cells). 2. A continuation of H3-TdR administration of 100 per cent labeled newborn rats throughout the first three weeks of neonatal life resulted cytokinetically in the same three different cell types. However, a larger fraction of reticular and endothelial cells as well as bone marrow lymphocytes remained labeled weeks and months after the last injection as compared with the first group of 100 per cent labeled animals. 3. An administration of C14-TdR to 100 per cent labeled newborn animals throughout the first 6 days after birth Showed that 30 to 40 per cent of the "resting" bone marrow cells have turned into a resting state before or at least at the time of birth. Forty per cent of these cells still had some proliferative capacity during the first 6 days of life. Twenty per cent showed in the first days after birth a rapid turnover whereas later on they acquired their final cytokinetic state. The possible influence of radiation toxicity on the time of establishment of resting cells is discussed. This approach appears of use to study the functional properties of resting bone marrow cell types in regenerative processes and the cellular origin in the bone marrow.

[1]  D. Howard,et al.  Regulation of erythropoiesis. XXII. Erythropoietin production in the newborn animal. , 1968, Blood.

[2]  G. Lucarelli,et al.  FETAL AND NEONATAL ERYTHROPOIESIS * , 1968, Annals of the New York Academy of Sciences.

[3]  S. Ebbe,et al.  REGULATION OF ERYTHROPOIESIS. XX. KINETICS OF RED CELL PRODUCTION * , 1968, Annals of the New York Academy of Sciences.

[4]  T. Fliedner,et al.  Complete labeling of all cell nuclei in newborn rats with H3-thymidine. A tool for the evaluation of rapidly and slowly proliferating cell systems. , 1968, Laboratory investigation; a journal of technical methods and pathology.

[5]  T. Fliedner,et al.  Autoradiographic studies on rapidly and slowly proliferating cell systems in neonatal bone marrow. , 1967, Helvetica medica acta.

[6]  W. R. Bruce,et al.  Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents Administered In Vivo , 1966 .

[7]  W. R. Bruce,et al.  A model for the action of vinblastine in vivo. , 1966, Biophysical journal.

[8]  G. Lucarelli,et al.  Regulation of Erythropoiesis XIX. Effect of Hypoxia on Erythropoiesis in the Newborn Animal.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[9]  J. Till,et al.  THE EFFECT OF DIFFERING DEMANDS FOR BLOOD CELL PRODUCTION ON DNA SYNTHESIS BY HEMOPOIETIC COLONY-FORMING CELLS OF MICE. , 1965, Blood.

[10]  W. R. Bruce,et al.  Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to tritiated thymidine. , 1965, Journal of the National Cancer Institute.

[11]  E. Cronkite,et al.  THE PROBLEM OF THE STEM CELL: OBSERVATIONS IN DOGS FOLLOWING NITROGEN MUSTARD. , 1965, The Journal of laboratory and clinical medicine.

[12]  T. Fliedner,et al.  THE FATE OF TRANSFUSED H3 THYMIDINE‐LABELED BONE‐MARROW CELLS IN IRRADIATED RECIPIENTS * , 1964, Annals of the New York Academy of Sciences.

[13]  L. Lajtha,et al.  KINETICS OF A BONE‐MARROW STEM‐CELL POPULATION , 1964, Annals of the New York Academy of Sciences.

[14]  L. Lajtha,et al.  Kinetic Model of a Bone‐Marrow Stem‐Cell Population , 1962, British journal of haematology.

[15]  R. Baserga,et al.  Further Observations on Induction of Tumors in Mice with Radioactive Thymidine.∗ , 1962 .

[16]  S. Rose,et al.  Determination of lymphocyte turnover by continuous infusion of H3 thymidine. , 1962, Blood.

[17]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.

[18]  S. Greenhouse,et al.  Implication of Chromosome Structure and Replication on Hazard of Tritiated Thymidine and the Interpretation of Data on Cell Proliferation , 1961, Nature.

[19]  H. Quastler,et al.  DYNAMICS OF HEMOPOIETIC PROLIFERATION IN MAN AND MICE STUDIED BY H3‐THYMIDINE INCORPORATION INTO DNA * , 1959, Annals of the New York Academy of Sciences.

[20]  W. T. Burke,et al.  The changing cellular distribution in bone marrow of the normal albino rat between one and fifty weeks of age. , 1957, The American journal of pathology.